[CUE] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
30-Dec-2016
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -296.99%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 14,941 3,154 3,458 1,143 0 0 0 -
PBT -43,666 -44,579 -36,286 -38,155 -23,234 -7,658 -1,929 68.11%
Tax 495 206 412 825 0 0 0 -
NP -44,161 -44,785 -36,698 -38,980 -23,234 -7,658 -1,929 68.42%
Tax Rate - - - - - - - -
Total Cost 59,103 47,939 40,156 40,123 23,234 7,658 1,929 76.80%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -295.56 -1,419.79 -1,061.25 -3,411.53 0.00 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -1.41 -1.56 -1.66 -1.94 -1.13 -0.37 -0.09 58.11%
EPS Diluted -1.41 -1.56 -1.66 -1.94 -1.13 -0.37 -0.09 58.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.